[
  {
    "role": "user",
    "content": "It's 7/24/2025, 6:56:07 PM. Time for your trading analysis! Review your portfolio, scan the markets for opportunities, and make strategic trades to grow your initial $10000 investment. Good luck! üìà"
  },
  {
    "type": "reasoning",
    "id": "rs_688281c9de508199a84886bbc821cbd0049288b729dc41c2",
    "content": [],
    "providerData": {
      "id": "rs_688281c9de508199a84886bbc821cbd0049288b729dc41c2",
      "type": "reasoning"
    }
  },
  {
    "type": "function_call",
    "id": "fc_688281d1853c8199bcee9cb4cc365cfd049288b729dc41c2",
    "callId": "call_mUNCV9U5tVjJ2EQSySI779fQ",
    "name": "think",
    "status": "completed",
    "arguments": "{\"thought_process\":[\"1. We need to start by reviewing our current portfolio to see cash, holdings, and recent performance.\",\"2. After obtaining portfolio details, evaluate cash available and positions.\",\"3. Conduct market scan via web_search for today's top movers, news, and sectors with momentum (especially after-hours).\",\"4. Identify 2-3 candidate tickers with strong momentum, reasonable liquidity, and catalysts.\",\"5. Retrieve current prices for those tickers to assess sizing.\",\"6. Decide whether to buy, sell, or hold existing positions based on performance and new opportunities.\",\"7. Execute trades while keeping risk management ‚Äì avoid concentrating more than ~30% capital in one position and keep at least 20% cash reserve.\",\"8. Recalculate projected cash usage before placing any orders.\"]}",
    "providerData": {
      "id": "fc_688281d1853c8199bcee9cb4cc365cfd049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "think",
    "callId": "call_mUNCV9U5tVjJ2EQSySI779fQ",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "Completed thinking with 8 steps of reasoning."
    }
  },
  {
    "type": "function_call",
    "id": "fc_688282099a848199988d9d4beb281edc049288b729dc41c2",
    "callId": "call_UUFSwU41hIR6L34VvgNhJJ8i",
    "name": "get_portfolio",
    "status": "completed",
    "arguments": "{}",
    "providerData": {
      "id": "fc_688282099a848199988d9d4beb281edc049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "get_portfolio",
    "callId": "call_UUFSwU41hIR6L34VvgNhJJ8i",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "Your cash balance is $10000.\nCurrent holdings:\n\n\nTrade history:\n"
    }
  },
  {
    "type": "reasoning",
    "id": "rs_68828210255c8199960b9559c5d72cd5049288b729dc41c2",
    "content": [],
    "providerData": {
      "id": "rs_68828210255c8199960b9559c5d72cd5049288b729dc41c2",
      "type": "reasoning"
    }
  },
  {
    "type": "function_call",
    "id": "fc_68828213404c8199ab9ff27b5eae922b049288b729dc41c2",
    "callId": "call_ltsdTiRoW1TJahxi2J6wQ0vc",
    "name": "think",
    "status": "completed",
    "arguments": "{\"thought_process\":[\"1. We currently hold all cash ($10,000).\",\"2. Need to identify potential opportunities. Because we are fully cash, we can allocate across 2-3 positions.\",\"3. Perform web search for today's (7/24/2025) market top gainers, after-hours movers, and any breaking news.\",\"4. Specifically look for momentum plays in technology, biotech, or AI sectors, or earnings beat plays.\",\"5. From search results, pick 2-3 tickers with strong catalysts and high volume.\",\"6. Retrieve current prices for those tickers to plan position sizes (roughly $3k each, leaving $1k cash reserve).\"]}",
    "providerData": {
      "id": "fc_68828213404c8199ab9ff27b5eae922b049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "think",
    "callId": "call_ltsdTiRoW1TJahxi2J6wQ0vc",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "Completed thinking with 6 steps of reasoning."
    }
  },
  {
    "type": "function_call",
    "id": "fc_688282192dc881998d6279577327bc85049288b729dc41c2",
    "callId": "call_FHIGG8FXXgTyTICWTeB5lOV5",
    "name": "web_search",
    "status": "completed",
    "arguments": "{\"query\":\"US stock market top gainers and after-hours movers 7/24/2025\"}",
    "providerData": {
      "id": "fc_688282192dc881998d6279577327bc85049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "web_search",
    "callId": "call_FHIGG8FXXgTyTICWTeB5lOV5",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "### 7 / 24 / 2025 ‚Äì U.S. stock highlights  \n\n**Regular-session top gainers**  \n| Ticker | Move | Catalyst |\n|--------|-------|----------|\n| TMO | +9.1 % | Q2 earnings & revenue beat expectations ([nasdaq.com](https://www.nasdaq.com/articles/company-news-jul-24-2025?utm_source=chatgpt.com))  \n| GD  | +6.5 % | Better-than-expected Q2 profit ([nasdaq.com](https://www.nasdaq.com/articles/company-news-jul-24-2025?utm_source=chatgpt.com))  \n| BSX | +4.5 % | Q2 EPS beat on strong device demand ([nasdaq.com](https://www.nasdaq.com/articles/company-news-jul-24-2025?utm_source=chatgpt.com))  \n\n*(AT&T (T) also added ‚âà1 % but was less material.)*  \n\n**Largest after-hours movers (post-close Thursday)**  \nGainers  \n‚Ä¢ ServiceNow (NOW) +6.5 % ‚Äî beat Q2 estimates and raised FY-25 subscription-revenue outlook ([benzinga.com](https://www.benzinga.com/markets/earnings/25/07/46588820/servicenow-beats-q2-earnings-estimates-raises-2025-subscription-revenue-outlook-shares-charge-higher?utm_source=chatgpt.com))  \n‚Ä¢ Alphabet (GOOGL) +1.8 % ‚Äî Q2 revenue/EPS beat; AI-capex plans cheered ([stocktwits.com](https://stocktwits.com/news-articles/markets/equity/tsla-googl-avgo-nvda-amzn-stocks-most-active-after-hours/ch8yhAKR5u9))  \n‚Ä¢ Broadcom (AVGO) +2.8 %, Nvidia (NVDA) +1.2 %, Amazon (AMZN) +0.7 % ‚Äî AI-related momentum and deal news ([stocktwits.com](https://stocktwits.com/news-articles/markets/equity/tsla-googl-avgo-nvda-amzn-stocks-most-active-after-hours/ch8yhAKR5u9))  \n\nLosers  \n‚Ä¢ Chipotle (CMG) ‚àí9.8 % ‚Äî revenue miss and flat 2025 same-store-sales outlook ([benzinga.com](https://www.benzinga.com/news/25/07/46593358/chipotle-falls-about-9-after-hours-following-q2-results?utm_source=chatgpt.com), [investing.com](https://www.investing.com/equities/after-hours?utm_source=chatgpt.com))  \n‚Ä¢ IBM (IBM) ‚àí5.2 % ‚Äî solid Q2 but investors focused on softer software growth ([investing.com](https://www.investing.com/equities/after-hours?utm_source=chatgpt.com))  \n‚Ä¢ Tesla (TSLA) ‚àí4 ‚Äì 5 % ‚Äî second straight revenue decline; Musk warns of ‚Äúrough quarters‚Äù ahead ([stocktwits.com](https://stocktwits.com/news-articles/markets/equity/tsla-googl-avgo-nvda-amzn-stocks-most-active-after-hours/ch8yhAKR5u9), [blockchain.news](https://blockchain.news/flashnews/tesla-tsla-stock-plunges-nearly-5-after-hours-on-earnings-potential-impact-on-bitcoin-btc-and-crypto-market-sentiment?utm_source=chatgpt.com))  \n‚Ä¢ Molina Healthcare (MOH) ‚àí5.0 %, Packaging Corp (PKG) ‚àí4.0 % and several others also slid in the extended session ([investing.com](https://www.investing.com/equities/after-hours?utm_source=chatgpt.com))  \n\nThese figures capture the day‚Äôs biggest percentage winners during the regular market and the most notable price swings in the first hours of the after-market on July 24 , 2025."
    }
  },
  {
    "type": "reasoning",
    "id": "rs_688282cc2ba48199ba0344020f9524b3049288b729dc41c2",
    "content": [],
    "providerData": {
      "id": "rs_688282cc2ba48199ba0344020f9524b3049288b729dc41c2",
      "type": "reasoning"
    }
  },
  {
    "type": "function_call",
    "id": "fc_688282d71f8c819999b97d39be82577f049288b729dc41c2",
    "callId": "call_zsrsbR1qMAh13nBFoZEpwImT",
    "name": "think",
    "status": "completed",
    "arguments": "{\"thought_process\":[\"1. Decide to check current prices for NOW, TMO, NVDA to determine position sizing.\",\"2. Will allocate roughly $3000 to each; adjust based on share price and round to whole shares.\",\"3. Keep at least $1000 cash remain.\",\"4. Need to use get_stock_price for each ticker.\"]}",
    "providerData": {
      "id": "fc_688282d71f8c819999b97d39be82577f049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "think",
    "callId": "call_zsrsbR1qMAh13nBFoZEpwImT",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "Completed thinking with 4 steps of reasoning."
    }
  },
  {
    "type": "function_call",
    "id": "fc_688282ddaf7c81999ee9edb72d015263049288b729dc41c2",
    "callId": "call_TLoIb8EIv4umQlYR3u9J2wsk",
    "name": "get_stock_price",
    "status": "completed",
    "arguments": "{\"ticker\":\"NOW\"}",
    "providerData": {
      "id": "fc_688282ddaf7c81999ee9edb72d015263049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "get_stock_price",
    "callId": "call_TLoIb8EIv4umQlYR3u9J2wsk",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "989.2"
    }
  },
  {
    "type": "reasoning",
    "id": "rs_688282e46f6c81999cab54778287201a049288b729dc41c2",
    "content": [],
    "providerData": {
      "id": "rs_688282e46f6c81999cab54778287201a049288b729dc41c2",
      "type": "reasoning"
    }
  },
  {
    "type": "function_call",
    "id": "fc_688282e5447081998716938560afd413049288b729dc41c2",
    "callId": "call_Cs6MDBkXOjbmIgYpKjHX0eeF",
    "name": "get_stock_price",
    "status": "completed",
    "arguments": "{\"ticker\":\"TMO\"}",
    "providerData": {
      "id": "fc_688282e5447081998716938560afd413049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "get_stock_price",
    "callId": "call_Cs6MDBkXOjbmIgYpKjHX0eeF",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "478.14"
    }
  },
  {
    "type": "reasoning",
    "id": "rs_688282eff8b881998f85570d457fb0f3049288b729dc41c2",
    "content": [],
    "providerData": {
      "id": "rs_688282eff8b881998f85570d457fb0f3049288b729dc41c2",
      "type": "reasoning"
    }
  },
  {
    "type": "function_call",
    "id": "fc_688282f0a98c8199857575eafce32da6049288b729dc41c2",
    "callId": "call_dY0t80BUl7CLW7Hx0R4ts7Ea",
    "name": "get_stock_price",
    "status": "completed",
    "arguments": "{\"ticker\":\"NVDA\"}",
    "providerData": {
      "id": "fc_688282f0a98c8199857575eafce32da6049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "get_stock_price",
    "callId": "call_dY0t80BUl7CLW7Hx0R4ts7Ea",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "173.355"
    }
  },
  {
    "type": "reasoning",
    "id": "rs_688282ffd1488199b8e956363e504904049288b729dc41c2",
    "content": [],
    "providerData": {
      "id": "rs_688282ffd1488199b8e956363e504904049288b729dc41c2",
      "type": "reasoning"
    }
  },
  {
    "type": "function_call",
    "id": "fc_688283047158819994ff4f31914fbbd8049288b729dc41c2",
    "callId": "call_RReZO66LHpcsAS77fgmOKFJx",
    "name": "think",
    "status": "completed",
    "arguments": "{\"thought_process\":[\"1. Based on prices, invest:\\n   - NOW: 3 shares x 989.2 = $2,967.60\\n   - TMO: 6 shares x 478.14 = $2,868.84\\n   - NVDA: 17 shares x 173.355 = $2,947.04\\n   Total = $8,783.48 leaving ~$1,216.52 (12%) cash reserve.\\n\",\"2. Positions diversified across software (NOW), life sciences (TMO), and semis/AI (NVDA).\",\"3. Risk looks manageable; each position < 30% capital.\",\"4. Execute buys now.\"]}",
    "providerData": {
      "id": "fc_688283047158819994ff4f31914fbbd8049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "think",
    "callId": "call_RReZO66LHpcsAS77fgmOKFJx",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "Completed thinking with 4 steps of reasoning."
    }
  },
  {
    "type": "function_call",
    "id": "fc_6882830db57c819989476eb177b8ca0a049288b729dc41c2",
    "callId": "call_86azYxoExNXGFoXIskmXNMr2",
    "name": "buy",
    "status": "completed",
    "arguments": "{\"ticker\":\"NOW\",\"shares\":3}",
    "providerData": {
      "id": "fc_6882830db57c819989476eb177b8ca0a049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "buy",
    "callId": "call_86azYxoExNXGFoXIskmXNMr2",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "Purchased 3 shares of NOW at $989.2 per share, for a total of $2967.6000000000004. Your cash balance is now $7032.4."
    }
  },
  {
    "type": "reasoning",
    "id": "rs_688283141a148199aaf23b316db1f7a7049288b729dc41c2",
    "content": [],
    "providerData": {
      "id": "rs_688283141a148199aaf23b316db1f7a7049288b729dc41c2",
      "type": "reasoning"
    }
  },
  {
    "type": "function_call",
    "id": "fc_688283149dc4819994bc0bfb6ada432b049288b729dc41c2",
    "callId": "call_txRkKmcv8CRF24JU1er1e6aS",
    "name": "buy",
    "status": "completed",
    "arguments": "{\"ticker\":\"TMO\",\"shares\":6}",
    "providerData": {
      "id": "fc_688283149dc4819994bc0bfb6ada432b049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "buy",
    "callId": "call_txRkKmcv8CRF24JU1er1e6aS",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "Purchased 6 shares of TMO at $477.03 per share, for a total of $2862.18. Your cash balance is now $4170.22."
    }
  },
  {
    "type": "reasoning",
    "id": "rs_6882831b5ea081999a5a904edb0c9fdd049288b729dc41c2",
    "content": [],
    "providerData": {
      "id": "rs_6882831b5ea081999a5a904edb0c9fdd049288b729dc41c2",
      "type": "reasoning"
    }
  },
  {
    "type": "function_call",
    "id": "fc_6882831c20388199a1bbf849ccabb53e049288b729dc41c2",
    "callId": "call_sUeVx4Scuy2iaWDlk94DtNAy",
    "name": "buy",
    "status": "completed",
    "arguments": "{\"ticker\":\"NVDA\",\"shares\":17}",
    "providerData": {
      "id": "fc_6882831c20388199a1bbf849ccabb53e049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "buy",
    "callId": "call_sUeVx4Scuy2iaWDlk94DtNAy",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "Purchased 17 shares of NVDA at $173.355 per share, for a total of $2947.035. Your cash balance is now $1223.19."
    }
  },
  {
    "type": "reasoning",
    "id": "rs_68828321d62c8199a6e4cb8177e8ac95049288b729dc41c2",
    "content": [],
    "providerData": {
      "id": "rs_68828321d62c8199a6e4cb8177e8ac95049288b729dc41c2",
      "type": "reasoning"
    }
  },
  {
    "type": "function_call",
    "id": "fc_68828322972c8199b71574a995b8bbdc049288b729dc41c2",
    "callId": "call_41fpXcdFz6VXsaguI13PtryS",
    "name": "think",
    "status": "completed",
    "arguments": "{\"thought_process\":[\"1. We successfully purchased NOW, TMO, NVDA and have $1,223.19 cash (~12%).\",\"2. Portfolio diversified with three momentum plays post-earnings (NOW, TMO) and AI leader (NVDA).\",\"3. Next steps in future runs: monitor price action, consider scaling out on further strength or cutting losses if momentum fades.\",\"4. For now, hold positions and keep cash reserve for opportunities or risk management.\"]}",
    "providerData": {
      "id": "fc_68828322972c8199b71574a995b8bbdc049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "think",
    "callId": "call_41fpXcdFz6VXsaguI13PtryS",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "Completed thinking with 4 steps of reasoning."
    }
  },
  {
    "id": "msg_688283283690819985c3ae715ea3c148049288b729dc41c2",
    "type": "message",
    "role": "assistant",
    "content": [
      {
        "type": "output_text",
        "text": "Trades executed:\n\n1. Bought 3 shares NOW @ $989.20 = $2,967.60  \n2. Bought 6 shares TMO @ $477.03 = $2,862.18  \n3. Bought 17 shares NVDA @ $173.36 = $2,947.04  \n\nCash remaining: $1,223.19 (‚âà12% of capital)  \nCurrent holdings:\n‚Ä¢ NOW 3 sh  \n‚Ä¢ TMO 6 sh  \n‚Ä¢ NVDA 17 sh  \n\nRationale:\n‚Ä¢ ServiceNow (NOW): strong Q2 beat, guidance raise, +6.5 % after-hours momentum.  \n‚Ä¢ Thermo Fisher (TMO): 9 % regular-session gain on earnings; potential follow-through.  \n‚Ä¢ Nvidia (NVDA): AI sector leader, fresh upside after-hours.  \n\nEach position <30 % of portfolio, leaving cash buffer for flexibility.  \nPlan: monitor price action over the next sessions; take profits on sustained strength or cut losses if momentum fades, while scouting new opportunities with the remaining cash.",
        "annotations": [],
        "logprobs": []
      }
    ],
    "status": "completed",
    "providerData": {}
  },
  {
    "role": "user",
    "content": "It's 7/25/2025, 3:12:23 PM. Time for your trading analysis! Review your portfolio, scan the markets for opportunities, and make strategic trades to grow your initial $10000 investment. Good luck! üìà"
  },
  {
    "type": "reasoning",
    "id": "rs_68839edac81c819997d420048dd06037049288b729dc41c2",
    "content": [],
    "providerData": {
      "id": "rs_68839edac81c819997d420048dd06037049288b729dc41c2",
      "type": "reasoning"
    }
  },
  {
    "type": "function_call",
    "id": "fc_68839edec5c48199bf810954ee875b97049288b729dc41c2",
    "callId": "call_cWfR3z6a7qAd1zjAuHKP3vwL",
    "name": "think",
    "status": "completed",
    "arguments": "{\"thought_process\":[\"1. It's the next run; need to review portfolio to see current market value and P/L.\",\"2. After portfolio view, get current stock prices for holdings (NOW, TMO, NVDA) to evaluate gain/loss relative to cost.\",\"3. Assess market conditions: search for intraday news/update on these tickers and other movers.\",\"4. Decide whether to trim or add positions, or enter new trades using cash.\",\"5. Maintain risk management; hold 20% cash if feasible.\",\"6. Plan to possibly scale out partial profits if gain >5% from entry.\",\"7. If any position down >4% consider stop loss.\",\"8. Search for new momentum names today (earnings beats etc.).\"]}",
    "providerData": {
      "id": "fc_68839edec5c48199bf810954ee875b97049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "think",
    "callId": "call_cWfR3z6a7qAd1zjAuHKP3vwL",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "Completed thinking with 8 steps of reasoning."
    }
  },
  {
    "type": "function_call",
    "id": "fc_68839ee91c4c8199ae824b1f5173e28e049288b729dc41c2",
    "callId": "call_sA3jMbVz4n7j7R1ffuIgOptL",
    "name": "get_portfolio",
    "status": "completed",
    "arguments": "{}",
    "providerData": {
      "id": "fc_68839ee91c4c8199ae824b1f5173e28e049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "get_portfolio",
    "callId": "call_sA3jMbVz4n7j7R1ffuIgOptL",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "Your cash balance is $1223.19.\nCurrent holdings:\n  - NOW: 3 shares\n  - TMO: 6 shares\n  - NVDA: 17 shares\n\nTrade history:\n  - 2025-07-24T19:01:38.555Z buy NOW 3 shares at $989.2 per share, for a total of $2967.6000000000004\n  - 2025-07-24T19:01:45.320Z buy TMO 6 shares at $477.03 per share, for a total of $2862.18\n  - 2025-07-24T19:01:52.307Z buy NVDA 17 shares at $173.355 per share, for a total of $2947.035"
    }
  },
  {
    "type": "function_call",
    "id": "fc_68839eef13088199b30d1fdb47049c85049288b729dc41c2",
    "callId": "call_e9PKgkyEnZZHu6Hp7iOINE7S",
    "name": "think",
    "status": "completed",
    "arguments": "{\"thought_process\":[\"1. Need current prices for NOW, TMO, NVDA.\",\"2. Use get_stock_price for each.\"]}",
    "providerData": {
      "id": "fc_68839eef13088199b30d1fdb47049c85049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "think",
    "callId": "call_e9PKgkyEnZZHu6Hp7iOINE7S",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "Completed thinking with 2 steps of reasoning."
    }
  },
  {
    "type": "function_call",
    "id": "fc_68839ef961748199a5ec51bc2e229edd049288b729dc41c2",
    "callId": "call_bqeSonGCgkqJHPjWE1JC7qaf",
    "name": "get_stock_price",
    "status": "completed",
    "arguments": "{\"ticker\":\"NOW\"}",
    "providerData": {
      "id": "fc_68839ef961748199a5ec51bc2e229edd049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "get_stock_price",
    "callId": "call_bqeSonGCgkqJHPjWE1JC7qaf",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "975.57"
    }
  },
  {
    "type": "reasoning",
    "id": "rs_68839f0b02a48199bf9e0ac8ea5bcd64049288b729dc41c2",
    "content": [],
    "providerData": {
      "id": "rs_68839f0b02a48199bf9e0ac8ea5bcd64049288b729dc41c2",
      "type": "reasoning"
    }
  },
  {
    "type": "function_call",
    "id": "fc_68839f0c73b88199b15937bc92c74bf3049288b729dc41c2",
    "callId": "call_uUL0Ga9wEdfSk9a8dRa275mz",
    "name": "get_stock_price",
    "status": "completed",
    "arguments": "{\"ticker\":\"TMO\"}",
    "providerData": {
      "id": "fc_68839f0c73b88199b15937bc92c74bf3049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "get_stock_price",
    "callId": "call_uUL0Ga9wEdfSk9a8dRa275mz",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "479.6"
    }
  },
  {
    "type": "reasoning",
    "id": "rs_68839f1b04f081999301aa35027aac61049288b729dc41c2",
    "content": [],
    "providerData": {
      "id": "rs_68839f1b04f081999301aa35027aac61049288b729dc41c2",
      "type": "reasoning"
    }
  },
  {
    "type": "function_call",
    "id": "fc_68839f1f72c88199a8d2e66fd60419a9049288b729dc41c2",
    "callId": "call_h6n8F3B7S0y0POtMwpvWEXr8",
    "name": "get_stock_price",
    "status": "completed",
    "arguments": "{\"ticker\":\"NVDA\"}",
    "providerData": {
      "id": "fc_68839f1f72c88199a8d2e66fd60419a9049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "get_stock_price",
    "callId": "call_h6n8F3B7S0y0POtMwpvWEXr8",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "173.99"
    }
  },
  {
    "type": "reasoning",
    "id": "rs_68839f315d388199ac95a8a7f8f6cce0049288b729dc41c2",
    "content": [],
    "providerData": {
      "id": "rs_68839f315d388199ac95a8a7f8f6cce0049288b729dc41c2",
      "type": "reasoning"
    }
  },
  {
    "type": "function_call",
    "id": "fc_68839f34ca5c81999088238d8f888ba0049288b729dc41c2",
    "callId": "call_sBMYR69HntGXuEEcj2xUGvkQ",
    "name": "think",
    "status": "completed",
    "arguments": "{\"thought_process\":[\"1. NOW slightly down (~1.4%), small unrealized loss. Not alarming, still above stop threshold (>4%).\",\"2. TMO and NVDA slightly green (~0.5%), also minimal movement.\",\"3. Since none triggered exit criteria, consider holding to give trades time.\",\"4. Could use available $1223 to open new position if good opportunity exists today.\",\"5. Search for today's top gainers and catalysts (7/25/2025 midday) to find strong movers.\",\"6. Focus on liquid names with volume; e.g., a biotech with FDA approval or an earnings beat.\",\"7. Will perform web_search to gather info.\"]}",
    "providerData": {
      "id": "fc_68839f34ca5c81999088238d8f888ba0049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "think",
    "callId": "call_sBMYR69HntGXuEEcj2xUGvkQ",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "Completed thinking with 7 steps of reasoning."
    }
  },
  {
    "type": "function_call",
    "id": "fc_68839f4703ec8199b8a3be09eb475293049288b729dc41c2",
    "callId": "call_pIjNR4DwOK2AIQHG00OMzKat",
    "name": "web_search",
    "status": "completed",
    "arguments": "{\"query\":\"US stock market midday top gainers 7/25/2025 biotech fda approval earnings beat\"}",
    "providerData": {
      "id": "fc_68839f4703ec8199b8a3be09eb475293049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "web_search",
    "callId": "call_pIjNR4DwOK2AIQHG00OMzKat",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "**Mid-day U.S. movers ‚Äì Fri July 25 2025**\n\n| Ticker | Mid-session gain | Catalyst |\n|--------|------------------|----------|\n| **FIX** | ‚âà +17 % | Q2 EPS and revenue smashed estimates; company also boosted its dividend ([barrons.com](https://www.barrons.com/articles/stock-movers-58f909d1?utm_source=chatgpt.com)) |\n| **DECK** | ‚âà +13 % | FY-26 Q1 profit and sales beat; Hoka & UGG demand powered guidance hike ([barrons.com](https://www.barrons.com/articles/stock-movers-58f909d1?utm_source=chatgpt.com)) |\n| **ALNY** | ‚âà +7 % | FDA expanded approval of heart-disease drug Amvuttra (first treatment that now covers both ATTR-CM and neuropathy forms) ([tradingview.com](https://www.tradingview.com/news/reuters.com%2C2025%3Anewsml_L4N3Q40NM%3A0-alnylam-shares-rise-on-expanded-heart-drug-approval/?utm_source=chatgpt.com)) |\n| **NEM** | ‚âà +7 % | Q2 earnings beat forecasts; announced new $3 bn buyback ([barrons.com](https://www.barrons.com/articles/stock-movers-58f909d1?utm_source=chatgpt.com), [reuters.com](https://www.reuters.com/business/wall-street-inches-up-trumps-eu-trade-remarks-fed-hints-stir-caution-2025-07-25/)) |\n| **CNC** | ‚âà +5-6 % | Managed-care firm rose despite surprise loss as revenue jumped 22 % y/y ([barrons.com](https://www.barrons.com/articles/stock-movers-58f909d1?utm_source=chatgpt.com)) |\n\nKey take-aways  \n‚Ä¢ The day‚Äôs biggest percentage gainers came from earnings beats in industrials/consumer names (Comfort Systems, Deckers) and a gold-miner surprise (Newmont).  \n‚Ä¢ Biotech action was led by Alnylam; the FDA nod added >$1 bn in market value by midday as investors focused on its larger addressable market.  \n‚Ä¢ Health-care insurers and media also chipped in after mixed results (Centene) and merger clearance (Paramount), helping the S&P 500 cling to fresh record territory while Intel‚Äôs post-earnings slide capped the Nasdaq. ([reuters.com](https://www.reuters.com/business/wall-street-inches-up-trumps-eu-trade-remarks-fed-hints-stir-caution-2025-07-25/))"
    }
  },
  {
    "type": "reasoning",
    "id": "rs_6883a16f64c48199b1280a71656a885e049288b729dc41c2",
    "content": [],
    "providerData": {
      "id": "rs_6883a16f64c48199b1280a71656a885e049288b729dc41c2",
      "type": "reasoning"
    }
  },
  {
    "type": "function_call",
    "id": "fc_6883a175c9b081999e30cff7bd406e31049288b729dc41c2",
    "callId": "call_31jTBGIIqiIWpdlv1kNK1gCX",
    "name": "think",
    "status": "completed",
    "arguments": "{\"thought_process\":[\"1. Decide to consider ALNY; get its price.\",\"2. Possibly buy small position with $400-500 if liquidity good.\",\"3. We'll need get_stock_price(ALNY).\"]}",
    "providerData": {
      "id": "fc_6883a175c9b081999e30cff7bd406e31049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "think",
    "callId": "call_31jTBGIIqiIWpdlv1kNK1gCX",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "Completed thinking with 3 steps of reasoning."
    }
  },
  {
    "type": "function_call",
    "id": "fc_6883a17aafdc8199800f0314d7e30ff8049288b729dc41c2",
    "callId": "call_l1TMge2lpnFtlQhd4mObjcu0",
    "name": "get_stock_price",
    "status": "completed",
    "arguments": "{\"ticker\":\"ALNY\"}",
    "providerData": {
      "id": "fc_6883a17aafdc8199800f0314d7e30ff8049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "get_stock_price",
    "callId": "call_l1TMge2lpnFtlQhd4mObjcu0",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "326.64"
    }
  },
  {
    "type": "reasoning",
    "id": "rs_6883a18302608199b6dc8ce4195e299e049288b729dc41c2",
    "content": [],
    "providerData": {
      "id": "rs_6883a18302608199b6dc8ce4195e299e049288b729dc41c2",
      "type": "reasoning"
    }
  },
  {
    "type": "function_call",
    "id": "fc_6883a18424208199bfc2e0cb3071a5c4049288b729dc41c2",
    "callId": "call_IYA2UMYcH8gYsfPTTF2aOT9O",
    "name": "get_stock_price",
    "status": "completed",
    "arguments": "{\"ticker\":\"FIX\"}",
    "providerData": {
      "id": "fc_6883a18424208199bfc2e0cb3071a5c4049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "get_stock_price",
    "callId": "call_IYA2UMYcH8gYsfPTTF2aOT9O",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "660"
    }
  },
  {
    "type": "reasoning",
    "id": "rs_6883a18b29f08199ba3869451867fcd6049288b729dc41c2",
    "content": [],
    "providerData": {
      "id": "rs_6883a18b29f08199ba3869451867fcd6049288b729dc41c2",
      "type": "reasoning"
    }
  },
  {
    "type": "function_call",
    "id": "fc_6883a190378481998210dce6b40bc505049288b729dc41c2",
    "callId": "call_Z7Oyt0o0AnxEtc8r3Rm8GWxY",
    "name": "think",
    "status": "completed",
    "arguments": "{\"thought_process\":[\"1. Our current positions roughly breakeven; letting them play out may yield further gains.\",\"2. Taking a marginal $326 ALNY position won't meaningfully impact portfolio; but increases diversification and uses some cash, leaving ~ $900. FDA approval may continue momentum near-term.\",\"3. Risk manageable; biotech though volatile, allocate 1 share.\",\"4. Do buy 1 share ALNY for $326.64.\",\"5. That leaves ~$896 cash (~9%), still acceptable reserve.\",\"6. Monitor ALNY closely in next run.\"]}",
    "providerData": {
      "id": "fc_6883a190378481998210dce6b40bc505049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "think",
    "callId": "call_Z7Oyt0o0AnxEtc8r3Rm8GWxY",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "Completed thinking with 6 steps of reasoning."
    }
  },
  {
    "type": "function_call",
    "id": "fc_6883a195e5dc81998894d18400bef1b4049288b729dc41c2",
    "callId": "call_amusvIfKdA22jjafBHYMgh0y",
    "name": "buy",
    "status": "completed",
    "arguments": "{\"ticker\":\"ALNY\",\"shares\":1}",
    "providerData": {
      "id": "fc_6883a195e5dc81998894d18400bef1b4049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "buy",
    "callId": "call_amusvIfKdA22jjafBHYMgh0y",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "Purchased 1 shares of ALNY at $326.64 per share, for a total of $326.64. Your cash balance is now $896.55."
    }
  },
  {
    "type": "function_call",
    "id": "fc_6883a19e08288199888649bdcf1fb6ab049288b729dc41c2",
    "callId": "call_z3INIrIBbDVBpYZhH3jyOY11",
    "name": "think",
    "status": "completed",
    "arguments": "{\"thought_process\":[\"1. Portfolio now: NOW 3 sh, TMO 6 sh, NVDA 17 sh, ALNY 1 sh, cash $896.55 (~9%).\",\"2. Satisfied with diversification and cash level.\",\"3. Plan: keep monitoring.\",\"4. No further trades this run.\"]}",
    "providerData": {
      "id": "fc_6883a19e08288199888649bdcf1fb6ab049288b729dc41c2",
      "type": "function_call"
    }
  },
  {
    "type": "function_call_result",
    "name": "think",
    "callId": "call_z3INIrIBbDVBpYZhH3jyOY11",
    "status": "completed",
    "output": {
      "type": "text",
      "text": "Completed thinking with 4 steps of reasoning."
    }
  },
  {
    "id": "msg_6883a1a17d9081999735da8c98053bde049288b729dc41c2",
    "type": "message",
    "role": "assistant",
    "content": [
      {
        "type": "output_text",
        "text": "Trades executed this run:\n\n‚Ä¢ Bought 1 share ALNY @ $326.64 (FDA-expanded approval momentum)\n\nCurrent portfolio\n1. NOW 3 sh @ 989.20 (cost) ‚Äì current 975.57 (-1.4%)\n2. TMO 6 sh @ 477.03 ‚Äì current 479.60 (+0.5%)\n3. NVDA 17 sh @ 173.36 ‚Äì current 173.99 (+0.4%)\n4. ALNY 1 sh @ 326.64 ‚Äì current 326.64 (new)\nCash reserve: $896.55 (~9% of portfolio)\n\nReasoning:\n‚Ä¢ Existing holdings essentially flat; no exit triggers hit.\n‚Ä¢ Added ALNY for catalyst-driven momentum after FDA label expansion; small size keeps risk low while adding upside exposure.\n‚Ä¢ Maintain nearly 10 % cash for flexibility and risk management.\n\nNext steps:\n‚Äì Continue monitoring earnings-driven momentum in NOW, TMO, NVDA.\n‚Äì Watch ALNY‚Äôs follow-through; be ready to trim if biotech volatility spikes.\n‚Äì Search for fresh catalysts/earnings beats in the next session to deploy remaining cash or rotate out of laggards.",
        "annotations": [],
        "logprobs": []
      }
    ],
    "status": "completed",
    "providerData": {}
  }
]